收费全文 | 19730篇 |
免费 | 1092篇 |
国内免费 | 95篇 |
耳鼻咽喉 | 240篇 |
儿科学 | 461篇 |
妇产科学 | 293篇 |
基础医学 | 2488篇 |
口腔科学 | 546篇 |
临床医学 | 1380篇 |
内科学 | 5487篇 |
皮肤病学 | 404篇 |
神经病学 | 1682篇 |
特种医学 | 360篇 |
外科学 | 3033篇 |
综合类 | 130篇 |
一般理论 | 6篇 |
预防医学 | 1473篇 |
眼科学 | 524篇 |
药学 | 1060篇 |
1篇 | |
中国医学 | 50篇 |
肿瘤学 | 1299篇 |
2023年 | 137篇 |
2022年 | 119篇 |
2021年 | 637篇 |
2020年 | 340篇 |
2019年 | 647篇 |
2018年 | 759篇 |
2017年 | 422篇 |
2016年 | 462篇 |
2015年 | 569篇 |
2014年 | 736篇 |
2013年 | 961篇 |
2012年 | 1601篇 |
2011年 | 1702篇 |
2010年 | 907篇 |
2009年 | 876篇 |
2008年 | 1375篇 |
2007年 | 1376篇 |
2006年 | 1316篇 |
2005年 | 1240篇 |
2004年 | 1076篇 |
2003年 | 953篇 |
2002年 | 833篇 |
2001年 | 218篇 |
2000年 | 198篇 |
1999年 | 199篇 |
1998年 | 122篇 |
1997年 | 110篇 |
1996年 | 84篇 |
1995年 | 82篇 |
1994年 | 82篇 |
1993年 | 63篇 |
1992年 | 97篇 |
1991年 | 90篇 |
1990年 | 76篇 |
1989年 | 44篇 |
1988年 | 35篇 |
1987年 | 41篇 |
1986年 | 36篇 |
1985年 | 30篇 |
1984年 | 32篇 |
1983年 | 22篇 |
1982年 | 34篇 |
1981年 | 27篇 |
1980年 | 17篇 |
1979年 | 9篇 |
1978年 | 10篇 |
1977年 | 11篇 |
1975年 | 11篇 |
1974年 | 25篇 |
1973年 | 9篇 |
Chronic granulomatous disease (CGD) is an inherited immunodeficiency due to defective leukocyte NADPH responsible for recurrent infections and aberrant inflammation. Mutations in the CYBB gene are responsible for the X-linked CGD and account for approximately 70% of the cases. CGD is diagnosed during childhood in males. Female carriers may have biased X-inactivation and may present with clinical manifestations depending on the level of residual NADPH oxidase activity. We report the case of a previously asymptomatic female carrier who was diagnosed at age 67 with a skin infection with the rare fungus Paecilomyces lilacinus as the first manifestation of CGD. Dihydrorhodamine 123 (DHR) activity was below 10%. Next-generation sequencing (NGS) revealed mutations in DNMT3A, ASXL1, and STAG2 suggesting that clonal hematopoiesis could be responsible for a progressive loss of NADPH oxidase activity and the late onset of X-linked CGD in this patient. Long-term follow-up of asymptomatic carrier women seems to be essential after 50 years old.
相似文献We recently showed PAM50 gene expression data can be represented by five quantitative, orthogonal, multi-gene breast tumor traits. These novel tumor ‘dimensions’ were superior to categorical intrinsic subtypes for clustering in high-risk breast cancer pedigrees, indicating potential to represent underlying genetic susceptibilities and biological pathways. Here we explore the prognostic and predictive utility of these dimensions in a sub-study of GEICAM/9906, a Phase III randomized prospective clinical trial of paclitaxel in breast cancer.
MethodsTumor dimensions, PC1–PC5, were calculated using pre-defined coefficients. Univariable and multivariable Cox proportional hazards (PH) models for disease-free survival (DFS) were used to identify associations between quantitative dimensions and prognosis or response to the addition of paclitaxel. Results were illustrated using Kaplan–Meier curves.
ResultsDimensions PC1 and PC5 were associated with DFS (Cox PH p = 6.7 \(\times\) 10−7 and p = 0.036), remaining significant after correction for standard clinical–pathological prognostic characteristics. Both dimensions were selected in the optimal multivariable model, together with nodal status and tumor size (Cox PH p = 1.4 \(\times\) 10−12). Interactions with treatment were identified for PC3 and PC4. Response to paclitaxel was restricted to tumors with low PC3 and PC4 (log-rank p = 0.0021). Women with tumors high for PC3 or PC4 showed no survival advantage.
ConclusionsOur proof-of-concept application of quantitative dimensions illustrated novel findings and clinical utility beyond standard clinical–pathological characteristics and categorical intrinsic subtypes for prognosis and predicting chemotherapy response. Consideration of expression data as quantitative tumor dimensions offers new potential to identify clinically important patient subsets in clinical trials and advance precision medicine.
相似文献Methods: The purpose of this study was to examine the degree to which several personal factors and school characteristics affect and explain students’ self-determination. A total of 232 students with intellectual disability from Spain participated. Their self-determination level was assessed by the ARC-INICO Scale.
Results: Students with moderate levels of intellectual disability obtained significantly lower scores on self-determination than their peers with mild intellectual disability. There were significant differences in relation to the level of support needs and their experience with transition programs. The level of support needs was a significant predictor.
Conclusion: These findings contribute to current research in this field and practical implications were discussed. 相似文献